Fenofibrate therapy in reducing the progression of diabetic retinopathy: revisiting the FIELD and ACCORD-EYE studies through the LENS trial

Eye (Lond). 2024 Oct 22. doi: 10.1038/s41433-024-03410-9. Online ahead of print.

Maria S Varughese^{1

2}, Ananth U Nayak^{2

3}, Sarita Jacob^{4

5

6

7}

¹ University of Sheffield Medical School, Royal Hallamshire Hospital, Sheffield, UK.
² University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, North Staffordshire, UK.
³ School of Medicine, Faculty of Health, Keele University, North Staffordshire, UK.
⁴ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Sarita.Jacob@uhb.nhs.uk.
⁵ Institute of Clinical Sciences, University of Birmingham, Birmingham, UK. Sarita.Jacob@uhb.nhs.uk.
⁶ College of Life and Health Sciences, Aston University, Birmingham, UK. Sarita.Jacob@uhb.nhs.uk.
⁷ Birmingham, Solihull and Black Country Diabetic Eye Screening Programme, Birmingham, UK. Sarita.Jacob@uhb.nhs.uk.

No abstract available